Your browser doesn't support javascript.
loading
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Lin, Bowen; Koibuchi, Nobutaka; Hasegawa, Yu; Sueta, Daisuke; Toyama, Kensuke; Uekawa, Ken; Ma, MingJie; Nakagawa, Takashi; Kusaka, Hiroaki; Kim-Mitsuyama, Shokei.
Affiliation
  • Lin B; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. parkmoon1982@yahoo.co.jp.
  • Koibuchi N; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. koibuchi-circ@umin.ac.jp.
  • Hasegawa Y; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. fpmhasse@yahoo.co.jp.
  • Sueta D; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. daisukesueta@gmail.com.
  • Toyama K; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. k-toyama@kumamoto-u.ac.jp.
  • Uekawa K; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. 101r5102@st.kumamoto-u.ac.jp.
  • Ma M; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. mamingjie1124@yahoo.co.jp.
  • Nakagawa T; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. 113r5133@st.kumamoto-u.ac.jp.
  • Kusaka H; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. kusaka@kumamoto-u.ac.jp.
  • Kim-Mitsuyama S; Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjyo, Kumamoto, 860-8556, Japan. mitsuyam@gpo.kumamoto-u.ac.jp.
Cardiovasc Diabetol ; 13: 148, 2014 Oct 26.
Article in En | MEDLINE | ID: mdl-25344694
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzhydryl Compounds / Cardiovascular Diseases / Cognition Disorders / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Glucosides / Hypoglycemic Agents / Obesity Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2014 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzhydryl Compounds / Cardiovascular Diseases / Cognition Disorders / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Glucosides / Hypoglycemic Agents / Obesity Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2014 Type: Article Affiliation country: Japan